BusinessGlobal Healthcare

Cheap Generic Drugs from Emerging Markets Risky

1 Mins read

Poorly made medicines are a greater threat than counterfeit medications, according to Roger Bate and Julissa Milligan of the American Enterprise Institute in Washington. They write:

Poorly made medicines are a greater threat than counterfeit medications, according to Roger Bate and Julissa Milligan of the American Enterprise Institute in Washington. They write:

Patients in emerging markets want greater access to medicines, but supplying medicines cheaply is proving problematic. Part of the difficulty is the proliferation of illegal counterfeits in the poorest markets. Yet our new research shows that substandard medicines—those legally but poorly produced—pose an equally dangerous threat to patients.

Production flaws in developing countries will only be exacerbated by lower quality chemicals inputs from China, the world’s largest chemical supplier. Ingredients from India and China are now found in 80 percent of American pharmaceuticals and probably in higher volumes elsewhere.

Meanwhile, African manufacturers performed worst, yielding 8.3 percent failures overall, followed by Chinese, Vietnamese, and small Indian producers. In emerging markets, domestically made products were far more likely to fail than imported products.

   

Related posts
Global HealthcarePolicy & Law

Do HMOs Deserve A Bad Reputation? The Truth Of Managed Healthcare

3 Mins read
Have you ever heard people say that HMO health insurance is no good? It’s no secret that HMOs have a bad reputation,…
Global Healthcare

5 Serious Health Problems Caused By Poor Cleanliness

3 Mins read
There are a lot of things that we need to do to stay healthy. We need to eat right, get regular physicals…
BusinessMarketing

5 Creative Ways to Advertise in the Healthcare Industry

4 Mins read
The healthcare industry is a dynamic one, with medical innovations, patient needs, financial obligations and changing regulations driving caregivers and administrators to…